The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 27 08 2020
accepted: 16 12 2020
pubmed: 5 2 2021
medline: 24 8 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

The risk of a recurrent fragility fracture varies by age and sex, as by site and recency of sentinel fracture. The recency of prior fractures affects subsequent fracture risk. Variable recency may obscure other factors that affect subsequent fracture risk. The aim of this study was to quantify the effect of a sentinel fracture by site, age, and sex where the recency was held constant. The study used data from the Reykjavik Study fracture register that documented prospectively all fractures at all skeletal sites in a large sample of the population of Iceland. Fracture incidence was compared to that of the general population determined at fixed times after a sentinel fracture (humeral, clinical vertebral, forearm, hip, and minor fractures). Outcome fractures comprised a major osteoporotic fracture and hip fracture. Sentinel osteoporotic fractures were identified in 9504 men and women. Of these, 3616 individuals sustained a major osteoporotic fracture as the first subsequent fracture, of whom 1799 sustained a hip fracture. Hazard ratios for prior fracture were consistently higher in men than in women and decreased progressively with age. Hazard ratios varied according to the site of sentinel fracture with higher ratios for hip and vertebral fracture than for humerus, forearm, or minor osteoporotic fracture. The risk of a recurrent fragility fracture varies by age, sex, and site of sentinel fracture when recency is held constant.

Identifiants

pubmed: 33537845
doi: 10.1007/s00198-020-05803-4
pii: 10.1007/s00198-020-05803-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1547-1555

Subventions

Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom

Informations de copyright

© 2020. International Osteoporosis Foundation and National Osteoporosis Foundation.

Références

Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739
doi: 10.1359/jbmr.2000.15.4.721
Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ III, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382
doi: 10.1016/j.bone.2004.03.024
Haentjens P, Johnell O, Kanis JA, Bouillon R, Cooper C, Lamraski G, Vanderschuren D, Kauffman J-M, Boonen S (2004) Gender-related differences in short and long-term absolute risk of hip fracture after Colles’ or spine fracture: Colles’ fracture as an early and sensitive marker of skeletal fragility in men. J Bone Miner Res 19:1933–1944
doi: 10.1359/jbmr.040917
Hansen L, Petersen KD, Eriksen SA, Langdahl BL, Eiken PA, Brixen K, Abrahamsen B, Jensen JE, Harslof T, Vestergaard P (2015) Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective. Osteoporos Int 26:513–519
doi: 10.1007/s00198-014-2875-2
Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Pettersen C, De Laet C, Jonsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179
doi: 10.1007/s00198-003-1514-0
Finsen V, Benum P (1986) Past fractures indicate increased risk of hip fracture. Acta Orthop Scand 57:337–339
doi: 10.3109/17453678608994406
Gunnes M, Mellstrom D, Johnell O (1998) How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women. Acta Orthop Scand 69:508–512
doi: 10.3109/17453679808997788
Johnell O, Oden A, Caulin F, Kanis JA (2001) Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int 12:207–214
doi: 10.1007/s001980170131
Giangregorio LM, Leslie WD (2010) Manitoba Bone Density Program. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res 25:1400–1405
doi: 10.1002/jbmr.35
Dretakis KE, Dretakis EK, Papakitsou EF, Psarakis S, Steriopoulos K (1998) Possible predisposing factors for the second hip fracture. Calcif Tissue Int 62:366–369
doi: 10.1007/s002239900446
Nymark T, Lauritsen JM, Ovesen O, Röck ND (2006) Jeune B (2006) Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study. Osteoporos Int 17(9):1353–1357
doi: 10.1007/s00198-006-0125-y
Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323
doi: 10.1001/jama.285.3.320
Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 24:1299–1307
doi: 10.1359/jbmr.090207
van Geel TACM, van Helden S, Geusens PP, Winkens B, Dinant G-J (2016) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102
doi: 10.1136/ard.2008.092775
Johansson H, Siggeirsdóttir K, Harvey NC, Odén A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA (2017) Imminent risk of fracture after fracture. Osteoporos Int 28:775–780
doi: 10.1007/s00198-016-3868-0
Van Staa TP, Leufkens HGM, Cooper C (2002) Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 13:624–629
doi: 10.1007/s001980200084
Robinson CM, Royds M, Abraham A, McQueen MM, Court-Brown CM, Christie J (2002) Refractures in patients at least forty-five years old. A prospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg Am 84:1528–1533
doi: 10.2106/00004623-200209000-00004
Kanis JA, Johansson H, Odén A, Harvey NC, Gudnason V, Sanders K, Sigurdsson G, Siggeirsdottir K, Borgström F, McCloskey EV (2018) Characteristics of recurrent fractures. Osteoporos Int 29:1747–1757
doi: 10.1007/s00198-018-4502-0
Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu M, Vandenput L, McCloskey E (2020) Effects of the recency of sentinel fractures on conventional estimates of fracture probability using FRAX. Osteoporos Int 31:1817–1828
doi: 10.1007/s00198-020-05517-7
Bjornsson OJ, Davidsson D, Olafsson H et al (1979) Report XVIII. Health survey in the Reykjavik Area. — Men. Stages I–III, 1967–1968, 1970–1971 and 1974–1975. Participants, invitation, response etc. The Icelandic Heart Association (afgreidsla@hjarta.is), Reykjavík
Bjornsson G, Bjornsson OJ, Davidsson D et al (1982) Report abc XXIV. Health Survey in the Reykjavik Area. – Women. Stages I-III, 1968–1969, 1971-1972 and 1976-1978. Participants, invitation, response etc. The Icelandic Heart Association (afgreidsla@hjarta.is), Reykjavík
Siggeirsdottir K, Aspelund T, Sigurdsson G, Mogensen B, Chang M, Jonsdottir B, Eiriksdottir G, Launer LJ, Harris TB, Jonsson BY, Gudnason V (2007) Inaccuracy in self-report of fractures may underestimate association with health outcomes when compared with medical record based fracture registry. Eur J Epidemiol 22:631–639
doi: 10.1007/s10654-007-9163-9
Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12:417–427
doi: 10.1007/s001980170112
Breslow NE, Day NE (1987) Statistical methods in cancer research, vol 2. IARC Scientific Publications, no 32, Lyon, pp 131–135
Albertsson-Wikland K, Martensson A, Savendahl L, Niklasson A, Bang P, Dahlgren J, Gustafsson J, Kriström B, Norgren S, Pehrsson NG, Odén A (2016) Mortality is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics. J Clin Endocrinol Metab 101:2149–2159
doi: 10.1210/jc.2015-3951
Söreskog E, Ström O, Spångéus A, Åkesson KE, Borgström F, Banefelt J, Toth E, Libanati C, Charokopou M (2000) Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older. Bone 134:115286. https://doi.org/10.1016/j.bone.2020.115286
doi: 10.1016/j.bone.2020.115286
Kanis JA, on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, Sheffield. Available at http://www.shef.ac.uk/FRAX/index.htm . Accessed 3 Feb 2021
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey EV (2008b) FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385–397
doi: 10.1007/s00198-007-0543-5

Auteurs

J A Kanis (JA)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. w.j.pontefract@shef.ac.uk.
Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK. w.j.pontefract@shef.ac.uk.

H Johansson (H)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.

N C Harvey (NC)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

V Gudnason (V)

Icelandic Heart Association Research Institute, Kopavogur, Iceland.
University of Iceland, Reykjavik, Iceland.

G Sigurdsson (G)

Icelandic Heart Association Research Institute, Kopavogur, Iceland.

K Siggeirsdottir (K)

Icelandic Heart Association Research Institute, Kopavogur, Iceland.

M Lorentzon (M)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Geriatric Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

E Liu (E)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

L Vandenput (L)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

E V McCloskey (EV)

Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.
Mellanby Centre for Bone Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH